BACKGROUND: In the European Project On Genes in Hypertension (EPOGH), we investigated in 3 populations to what extent left ventricular mass (LVM) was associated with genetic variation in the angiotensin II receptors type 1 (AGTR1 A1166C) and type 2 (AGTR2 G1675A) while accounting for possible gene-gene interactions with the angiotensin-converting enzyme (ACE D/I) and angiotensinogen (AGT -532C/T) polymorphisms. METHODS AND RESULTS: We randomly recruited 221 nuclear families (384 parents, 431 offspring) in Cracow (Poland), Novosibirsk (Russia), and Mirano (Italy). Echocardiographic LVM was indexed to body surface area, adjusted for covariates, and subjected to multivariate analyses using generalized estimating equations and quantitative transmission disequilibrium tests in a population-based and family-based approach, respectively. For AGTR1 and AGTR2, there was no heterogeneity in the phenotype-genotype relations across populations. LVM index was unrelated to the AGTR1 A1166C polymorphism. In men, in the population- and family-based analyses, the allelic effects of the AGTR2 polymorphism on LVM index differed (P=0.01) according to sodium excretion. In women, this gene-environment interaction did not reach statistical significance. In untreated men, LVM index (4.2 g/m2 per 100 mmol) and left ventricular internal diameter (0.73 mm/100 mmol) increased (P<0.02) with higher sodium excretion in the presence of the G allele with an opposite tendency in A allele carriers. The ACE D/I polymorphism, together with the ACE genotype-by-sodium interaction term, significantly and independently improved the models relating LVM index to the AGTR2 polymorphism and the AGTR2 genotype-by-sodium interaction. CONCLUSIONS: The present findings support the hypothesis that in men the AGTR2 G1675A and the ACE D/I polymorphisms independently influence LVM and that salt intake modulates these genetic effects.
BACKGROUND: In the European Project On Genes in Hypertension (EPOGH), we investigated in 3 populations to what extent left ventricular mass (LVM) was associated with genetic variation in the angiotensin II receptors type 1 (AGTR1A1166C) and type 2 (AGTR2G1675A) while accounting for possible gene-gene interactions with the angiotensin-converting enzyme (ACE D/I) and angiotensinogen (AGT -532C/T) polymorphisms. METHODS AND RESULTS: We randomly recruited 221 nuclear families (384 parents, 431 offspring) in Cracow (Poland), Novosibirsk (Russia), and Mirano (Italy). Echocardiographic LVM was indexed to body surface area, adjusted for covariates, and subjected to multivariate analyses using generalized estimating equations and quantitative transmission disequilibrium tests in a population-based and family-based approach, respectively. For AGTR1 and AGTR2, there was no heterogeneity in the phenotype-genotype relations across populations. LVM index was unrelated to the AGTR1A1166C polymorphism. In men, in the population- and family-based analyses, the allelic effects of the AGTR2 polymorphism on LVM index differed (P=0.01) according to sodium excretion. In women, this gene-environment interaction did not reach statistical significance. In untreated men, LVM index (4.2 g/m2 per 100 mmol) and left ventricular internal diameter (0.73 mm/100 mmol) increased (P<0.02) with higher sodium excretion in the presence of the G allele with an opposite tendency in A allele carriers. The ACE D/I polymorphism, together with the ACE genotype-by-sodium interaction term, significantly and independently improved the models relating LVM index to the AGTR2 polymorphism and the AGTR2 genotype-by-sodium interaction. CONCLUSIONS: The present findings support the hypothesis that in men the AGTR2G1675A and the ACE D/I polymorphisms independently influence LVM and that salt intake modulates these genetic effects.
Authors: R R Lemos; S G de Lima; J E Gomes da Cunha; D F Oliveira; M B Rodrigues de Souza; C F J Ayres; M F P M Albuquerque; J R M Oliveira Journal: J Mol Neurosci Date: 2012-04-25 Impact factor: 3.444
Authors: H Wersching; K Guske; S Hasenkamp; C Hagedorn; S Schiwek; S Jansen; V Witte; J Wellmann; H Lohmann; K Duning; J Kremerskothen; S Knecht; E Brand; A Floel Journal: Neuropsychopharmacology Date: 2011-02-23 Impact factor: 7.853
Authors: Wolfgang Lieb; Jochen Graf; Anika Götz; Inke R König; Björn Mayer; Marcus Fischer; Jan Stritzke; Christian Hengstenberg; Stephan R Holmer; Angela Döring; Hannelore Löwel; Heribert Schunkert; Jeanette Erdmann Journal: J Mol Med (Berl) Date: 2005-11-11 Impact factor: 4.599
Authors: Ramachandran S Vasan; Nicole L Glazer; Janine F Felix; Wolfgang Lieb; Philipp S Wild; Stephan B Felix; Norbert Watzinger; Martin G Larson; Nicholas L Smith; Abbas Dehghan; Anika Grosshennig; Arne Schillert; Alexander Teumer; Reinhold Schmidt; Sekar Kathiresan; Thomas Lumley; Yurii S Aulchenko; Inke R König; Tanja Zeller; Georg Homuth; Maksim Struchalin; Jayashri Aragam; Joshua C Bis; Fernando Rivadeneira; Jeanette Erdmann; Renate B Schnabel; Marcus Dörr; Robert Zweiker; Lars Lind; Richard J Rodeheffer; Karin Halina Greiser; Daniel Levy; Talin Haritunians; Jaap W Deckers; Jan Stritzke; Karl J Lackner; Uwe Völker; Erik Ingelsson; Iftikhar Kullo; Johannes Haerting; Christopher J O'Donnell; Susan R Heckbert; Bruno H Stricker; Andreas Ziegler; Thorsten Reffelmann; Margaret M Redfield; Karl Werdan; Gary F Mitchell; Kenneth Rice; Donna K Arnett; Albert Hofman; John S Gottdiener; Andre G Uitterlinden; Thomas Meitinger; Maria Blettner; Nele Friedrich; Thomas J Wang; Bruce M Psaty; Cornelia M van Duijn; H-Erich Wichmann; Thomas F Munzel; Heyo K Kroemer; Emelia J Benjamin; Jerome I Rotter; Jacqueline C Witteman; Heribert Schunkert; Helena Schmidt; Henry Völzke; Stefan Blankenberg Journal: JAMA Date: 2009-07-08 Impact factor: 56.272
Authors: Jan A Staessen; Lutgarde Thijs; Katarzyna Stolarz-Skrzypek; Antonella Bacchieri; John Barton; Ezio Degli Espositi; Peter W de Leeuw; Mirosław Dłużniewski; Nicola Glorioso; Andrzej Januszewicz; Paolo Manunta; Viktor Milyagin; Yuri Nikitin; Miroslav Souček; Chiara Lanzani; Lorena Citterio; Mario Timio; Andrzej Tykarski; Patrizia Ferrari; Giovanni Valentini; Kalina Kawecka-Jaszcz; Giuseppe Bianchi Journal: Trials Date: 2011-01-14 Impact factor: 2.279
Authors: Richard L Seip; Jeff S Volek; Andreas Windemuth; Mohan Kocherla; Maria Luz Fernandez; William J Kraemer; Gualberto Ruaño Journal: Nutr Metab (Lond) Date: 2008-02-06 Impact factor: 4.169